Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Aug 5, 2025, before the open
10-Q filed Aug 5, 2025, 36 days after period end · 0001558370-25-010302
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $48.50M | $29.08M | $19.22M | $9.07M |
| Net Income | -$46.63M | -$32.26M | -$46.70M | -$45.00M |
| EPS Diluted |
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
| -$0.75 |
| -$0.55 |
| -$0.82 |
| -$0.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.